1. Lancet Oncol. 2016 Nov;17(11):e470. doi: 10.1016/S1470-2045(16)30522-8.

Sarcoma and germ-line DICER1 mutations.

de Kock L(1), Foulkes WD(2).

Author information:
(1)Department of Human Genetics, McGill University, Montréal, Quebec, Canada; 
Lady Davis Institute, Segal Cancer Centre, Jewish General Hospital, 3755 Cote 
Sainte Catherine Road, Montreal, Quebec H3T 1E2, Canada.
(2)Department of Human Genetics, McGill University, Montréal, Quebec, Canada; 
Lady Davis Institute, Segal Cancer Centre, Jewish General Hospital, 3755 Cote 
Sainte Catherine Road, Montreal, Quebec H3T 1E2, Canada; Department of Medical 
Genetics, Research Institute of the McGill University Health Centre, Montreal, 
Quebec, Canada; Program in Cancer Genetics, Department of Oncology and Human 
Genetics, McGill University, Montreal, Quebec, Canada. Electronic address: 
william.foulkes@mcgill.ca.

Comment in
    Lancet Oncol. 2016 Nov;17(11):e471. doi: 10.1016/S1470-2045(16)30527-7.

Comment on
    Lancet Oncol. 2016 Sep;17(9):1261-71. doi: 10.1016/S1470-2045(16)30147-4.

DOI: 10.1016/S1470-2045(16)30522-8
PMID: 27819237 [Indexed for MEDLINE]